Exploratory study of Fuxintongluo decoction in the treatment of diabetic peripheral neuropathy due to yang deficiency and cold coagulation

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052753

Enrollment

Unknown

Registered

2021-11-05

Start date

2021-11-04

Completion date

Unknown

Last updated

2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic peripheral neuropathy (DPN)

Interventions

Experimental group:Traditional Chinese Medicine

Control group:Western Medicine

Eligibility

Sex/Gender

All

Age

30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Conform to the diagnosis of type 2 diabetic peripheral neuropathy; 2. In line with TCM syndrome differentiation; Yang deficiency and cold congealing type; Yang deficiency and cold condensing type greater than 10 points; 3. Aged 30 to 75 years; 4. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Related neuropathy caused by other reasons, such as cervical and lumbar spine disease, cerebral infarction, etc.; nerve damage caused by various reasons; 2. Patients with heart, liver and kidney dysfunction; 3. Use other drugs to improve peripheral neuropathy; 4. Pregnant, lactating patients or those planning to become pregnant; 5. Those who are allergic to the study drug.

Design outcomes

Primary

Measure	Time frame
Toronto clinical score;	—

Secondary

Measure	Time frame
Yang deficiency cold coagulation symptom integral;Electromyography;Blood sugar;	—

Countries

China

Contacts

Public ContactLi Jiangminzi

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

lijiangminzi@163.com+86 13720039639

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026